Form 4 filings across 1 company. Net figures count open-market buys and sales only. EDGAR profile ↗
Lifetime net: -$53K
Reported holding is the most recent post-transaction share count on a Table I row.
How quickly this filer reports. Section 16 allows two business days from the transaction.
All 5 filings we hold were filed within the two-business-day deadline.
Counted in business days from the transaction date, or the deemed execution date where the filing reports one, excluding weekends and federal holidays. How this is measured · All late filings
The 10 most recent Form 4 transactions.
| Mar 19 | ANTX | AN2 Therapeutics, Inc. | AGRANT◆ | 50,150 | — | — | — | Open the original filing on SEC.gov |
| Mar 19 | ANTX | AN2 Therapeutics, Inc. | DTOISS◆ | 92,000 | — | — | — | Open the original filing on SEC.gov |
| Mar 19 | ANTX | AN2 Therapeutics, Inc. | AGRANT◆ | 92,000 | — | — | — | Open the original filing on SEC.gov |
| Feb 20 | ANTX | AN2 Therapeutics, Inc. | AGRANT◆ | 100,000 | — | — | — | Open the original filing on SEC.gov |
| Feb 20 | ANTX | AN2 Therapeutics, Inc. | AGRANT | 50,000 | — | — | +31.8% | Open the original filing on SEC.gov |
| Jan 6 | ANTX | AN2 Therapeutics, Inc. | SSELL | 6,931 | $1.01 | $7K | -4.3% | Open the original filing on SEC.gov |
| Jan 5 | ANTX | AN2 Therapeutics, Inc. | SSELL | 17,923 | $1.00 | $17.9K | -10.1% | Open the original filing on SEC.gov |
| Nov 4, 2025 | ANTX | AN2 Therapeutics, Inc. | SSELL | 2,819 | $1.14 | $3.2K | -1.6% | Open the original filing on SEC.gov |